Dasatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia in Japan

Clinical trial NCT01464411 · UNKNOWN

Trial details

NCT number: NCT01464411
Sponsor: Kanto CML Study Group
Status: UNKNOWN
Study type: OBSERVATIONAL

Leukemia, Myelogenous, Chronic, BCR-ABL Positive Myelogenous Leukemia, Chronic, Chronic Phase

Start date: 2011-07-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.